The H2 haplotype is related in some studies to late onset Alzheimer’s disease and frontotemporal dementia risk [15,16]; it is also associated with lower brain MAPT expression levels in Alzheimer’s disease (AD) patients [15]. This evidence concerns the gene MAPT and early-onset autosomal dominant Alzheimer disease.